Copyright
©The Author(s) 2022.
World J Gastroenterol. Apr 28, 2022; 28(16): 1656-1670
Published online Apr 28, 2022. doi: 10.3748/wjg.v28.i16.1656
Published online Apr 28, 2022. doi: 10.3748/wjg.v28.i16.1656
Table 1 The correlation between cancer susceptibility 20 expression and the clinicopathological factors of 50 gastric patients
| Characteristics | Number of cases | CASC20 expression | P value | |
| High (n = 26) | Low (n = 24) | |||
| Gender | 0.382 | |||
| Male | 23 | 14 | 9 | |
| Female | 27 | 12 | 15 | |
| Age | 0.546 | |||
| ≤ 55 | 22 | 13 | 9 | |
| > 55 | 28 | 13 | 15 | |
| TNM stage | 0.262 | |||
| I + II | 24 | 10 | 14 | |
| III | 26 | 16 | 10 | |
| Lymphatic metastasis | 0.011a | |||
| Positive | 25 | 18 | 7 | |
| Negative | 25 | 8 | 17 | |
| Differentiation | 0.073 | |||
| Moderate/well | 30 | 12 | 18 | |
| Poor | 20 | 14 | 6 | |
- Citation: Shan KS, Li WW, Ren W, Kong S, Peng LP, Zhuo HQ, Tian SB. LncRNA cancer susceptibility 20 regulates the metastasis of human gastric cancer cells via the miR-143-5p/MEMO1 molecular axis. World J Gastroenterol 2022; 28(16): 1656-1670
- URL: https://www.wjgnet.com/1007-9327/full/v28/i16/1656.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i16.1656
